Retail Clinics

  • Internet is go-to for health-and-wellness information, study shows

    NEW YORK The types of websites consumers turn to for health-and-wellness information and the reasons they go online for such information are greatly influenced by the stage of the condition they are experiencing and varies by ailment type, age and gender, according to research released Wednesday by Kantar Media.

     

  • FDA approves Par and Tris Pharma's generic Tussionex

    WOODCLIFF LAKE, N.J. The Food and Drug Administration has approved a generic treatment for cough and upper respiratory symptoms resulting from colds and allergies made by Par Pharmaceutical and Tris Pharma, Par said Tuesday.

    The FDA approved hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension. The drug is a generic version of UCB’s Tussionex, which has annual sales of around $226 million, according to IMS Health.

     

  • Take Care Health Systems' treatment of pharyngitis, upper respiratory infections exceeds national quality benchmarks

    CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, announced on Monday that treatment of pharyngitis and upper respiratory infections at its clinics exceed national quality benchmarks, according to an analysis of data collected through its EMR system by the Jefferson School of Population Health.

  • J&J chairman addresses McNeil 'phantom recall' before House committee

    WASHINGTON McNeil products soon will repopulate shelves, Johnson & Johnson chairman and CEO Bill Weldon shared on Thursday during his testimony before the House of Representatives Committee on Oversight and Government Reform.

     

  • Mylan's generic Wellbutrin XL enters market

    PITTSBURGH Mylan has launched a generic version of a common antidepressant, the company said Friday.

     

    Mylan announced the launch of bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths, a once-daily treatment for depression.

     

     

    The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL. Various versions of the drug had sales of around $752 million during the 12-month period ended in June, according to IMS Health.

     

  • Kaiser Family Foundation: Medicaid enrollment, spending rises; growth will continue

    WASHINGTON Due to the nation’s deep recession, states experienced rapid growth in their Medicaid enrollment and spending last year and expect additional growth, though at a slower pace, in fiscal year 2011, according to a survey of state Medicaid officials in all 50 states released Thursday by the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured.

     

  • FDA tentatively approves generic Crestor

    MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries.

    Sun announced Wednesday the tentative approval of rosuvastatin calcium tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths.

  • Decision Resources: Crohn's disease drug market will increase 31% by 2019

    BURLINGTON, Mass. The drug market for Crohn's disease treatments will see moderate growth over the next decade, Decision Resources reported Wednesday.

    The research firm projected that the market will increase a little more than 31%, from $3.2 billion in 2009 to $4.2 billion in 2019, in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Decision Resources said the the modest growth rate masks such market changes as new and emerging biologics, as well as generic competition.

  • Abbott's multipurpose disinfecting solution for contacts gets FDA OK

    ABBOTT PARK, Ill. Abbott has received market clearance from the Food and Drug Administration for RevitaLens Ocutec, a multipurpose disinfecting solution for silicone hydrogel and conventional soft contact lenses.

  • GSK, Mia Hamm to adults: 'Give your health a shot'

    PHILADELPHIA GlaxoSmithKline has tapped soccer star Mia Hamm for its public health campaign to emphasize the need for adults to make vaccinations part of their overall health-and-wellness goals.

    GSK's Give Your Health a Shot campaign underscores the need for adults to receive vaccinations as a preventative measure to protect their health. The campaign announcement followed the pertussis (whooping cough) outbreak that has affected California.

X
This ad will auto-close in 10 seconds